Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Brain Injuries D001930 4 associated lipids
Bronchial Diseases D001982 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Burns, Inhalation D002059 4 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyslexia D004410 3 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy D004827 35 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Gastritis D005756 27 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Injuries D006335 6 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemolysis D006461 131 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hynes AC et al. The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors. 2002 Reprod. Fertil. Dev. pmid:12617797
Li X and Luo H [Advances in pharmacological study of Piper kadsura (Choisy) Ohwi]. 2002 Zhong Yao Cai pmid:14748373
Kulikov VI and Muzya GI Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo. 2002 Biochemistry Mosc. pmid:12495421
Sibelius U et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. 2002 Crit. Care Med. pmid:12394960
Pawliczak R et al. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444032
MacKinnon AC et al. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. 2002 J. Immunol. pmid:12444147
Marrache AM et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. 2002 J. Immunol. pmid:12444157
Abu-Zidan FM and Windsor JA Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. 2002 Eur J Surg pmid:12440758
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
Ryan KL et al. Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating. 2002 Methods Find Exp Clin Pharmacol pmid:12168504
Takizawa T et al. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. 2002 J. Allergy Clin. Immunol. pmid:12170264
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
McLennan SV et al. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. 2002 Diabetes pmid:12145178
Claud EC et al. Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. 2002 Pediatr. Res. pmid:12149490
Unno N et al. Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. 2002 Surgery pmid:12110797
Parker MA et al. Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. 2002 J. Neurosci. Res. pmid:12111814
Ahamed J and Ali H Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. 2002 J. Biol. Chem. pmid:11934880
Chang HW et al. Platelet-activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness. 2002 Ann. Neurol. pmid:12112082
Ewer AK Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. 2002 Acta Paediatr Suppl pmid:12200892
Göggel R et al. Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels. 2002 Am. J. Respir. Crit. Care Med. pmid:12204861
Bazan H and Ottino P The role of platelet-activating factor in the corneal response to injury. 2002 Prog Retin Eye Res pmid:12207945
Teather LA et al. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. 2002 Brain Res. pmid:12133598
De Plaen IG et al. Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. 2002 Immunology pmid:12153521
Akisu M et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468264
Li L et al. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica. 2002 Eur. J. Pharmacol. pmid:12163102
Sakai H et al. Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2. 2002 J. Physiol. (Lond.) pmid:12181297
Roudebush WE et al. Embryonic platelet-activating factor: temporal expression of the ligand and receptor. 2002 J. Assist. Reprod. Genet. pmid:11958508
Calcerrada MC et al. PAF-stimulated protein tyrosine phosphorylation in hippocampus: involvement of NO synthase. 2002 Neurochem. Res. pmid:11958533
Fragopoulou E et al. Biologically active lipids with antiatherogenic properties from white wine and must. 2002 J. Agric. Food Chem. pmid:11958642
Lloberas N et al. The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. 2002 Transplant. Proc. pmid:11959179
Castellvi J et al. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. 2002 Transplant. Proc. pmid:11959181
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Börjesson A et al. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. 2002 Dig Liver Dis pmid:11990391
Larrucea S et al. Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. 2002 Blood pmid:11929771
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Ottino P et al. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. 2002 Exp. Eye Res. pmid:12014920
Michalis LK et al. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes. 2002 Curr Med Res Opin pmid:12017208
Zimmerman GA et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. 2002 Crit. Care Med. pmid:12004251
Silva AR et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. 2002 J. Immunol. pmid:11937571
Tachibana A et al. Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. 2002 Intervirology pmid:11937770
Kingston JK et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. 2002 Am. J. Vet. Res. pmid:11939312
Deo DD et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 J. Biol. Chem. pmid:11940567
Strait RT et al. Pathways of anaphylaxis in the mouse. 2002 J. Allergy Clin. Immunol. pmid:11941316
Xu N et al. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. 2002 Biochem. Biophys. Res. Commun. pmid:11944906
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Yoshida H et al. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. 2002 Brain Res. pmid:12106666
Jaracz S et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. 2002 J. Org. Chem. pmid:12076171
Downing SJ et al. Effect of inflammatory mediators on the physiology of the human Fallopian tube. 2002 Hum Fertil (Camb) pmid:12082208
Kato T et al. Mitochondrial calcium response in human transformed lymphoblastoid cells. 2002 Life Sci. pmid:12052442
Downing SJ et al. Effect of platelet-activating factor on the electrophysiology of the human Fallopian tube: early mediation of embryo-maternal dialogue? 2002 Reproduction pmid:12361471
Donnard M et al. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. 2002 Stem Cells pmid:12351810
Leung SW et al. Platelet-activating factor enhanced the pressor response of endothelin-1. 2002 J. Cardiovasc. Pharmacol. pmid:12352314
Brewer C et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. 2002 J. Neurochem. pmid:12354298
Marin V et al. Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type. 2002 Eur. J. Immunol. pmid:12355450
Beauchamp MH et al. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12356842
Michibayashi T Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. 2002 Int Angiol pmid:12384648
Haynes J and Obiako B Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11748055
Shigematsu S et al. Bradykinin-induced proinflammatory signaling mechanisms. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12388246
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Murohisa G et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. 2002 Liver pmid:12390475
Maniscalco M et al. Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects. 2002 Eur. J. Clin. Invest. pmid:12423328
Dun Y et al. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol. 2002 Methods Find Exp Clin Pharmacol pmid:12428428
Arai H Platelet-activating factor acetylhydrolase. 2002 Prostaglandins Other Lipid Mediat. pmid:12432911
Fallani A et al. Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin. 2002 Prostaglandins Other Lipid Mediat. pmid:12428690
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Gélinas DS et al. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. 2002 Br. J. Pharmacol. pmid:12429574
Mahmoud FF et al. In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. 2002 Transplant. Proc. pmid:12431672
Bussolati B et al. Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. 2002 Int. J. Cancer pmid:12209602
Cadwallader KA et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. 2002 J. Immunol. pmid:12218155
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Sakamoto H et al. Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity. 2002 J. Biol. Chem. pmid:12397078
Ichinowatari G et al. Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6. 2002 Eur. J. Pharmacol. pmid:11779582
Ueyama Y et al. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. 2002 J. Exp. Clin. Cancer Res. pmid:12636105
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Breschi MC et al. Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. 2002 Eur. J. Pharmacol. pmid:11864645
Tanaka Y et al. Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor. 2002 J. Autoimmun. pmid:11869042
Teruel MN and Meyer T Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. 2002 Science pmid:11884760
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
McClenahan DJ et al. In vitro evaluation of the role of platelet-activating factor and interleukin-8 in Mannheimia haemolytica-induced bovine pulmonary endothelial cell injury. 2002 Am. J. Vet. Res. pmid:11911574
Schwartzkopff F et al. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. 2002 J. Interferon Cytokine Res. pmid:11911809
Royal SJ et al. Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. 2002 Brain Res. pmid:11911856
Ko HM et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. 2002 Cancer Res. pmid:11912159
Ishiguro K et al. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. 2002 Planta Med. pmid:11914965
Talvani A et al. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. 2002 Infect. Immun. pmid:12117933
Rivera A et al. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. 2002 Blood pmid:11756192
Hanada K et al. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. 2002 J. Exp. Med. pmid:11781362
Fonteh AN Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools. 2002 Eur. J. Biochem. pmid:12153573
Ohshima N et al. Receptor-dependent metabolism of platelet-activating factor in murine macrophages. 2002 J. Biol. Chem. pmid:11786559
Stangl V et al. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. 2002 Cardiovasc. Res. pmid:11744010
Cheminade C et al. 1-O-alkylglycerols improve boar sperm motility and fertility. 2002 Biol. Reprod. pmid:11804958
Walterscheid JP et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. 2002 J. Exp. Med. pmid:11805144
Unno N et al. Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. 2002 Ann. Surg. pmid:11807372
Johansson S et al. A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. 2002 J. Nat. Prod. pmid:11809061
Nagase T et al. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. 2002 Am. J. Respir. Crit. Care Med. pmid:11790655
Roudebush WE et al. Relationship between platelet-activating factor concentration in rhesus monkey (Macaca mulatta) spermatozoa and sperm motility. 2002 Am. J. Primatol. pmid:11793409
Drost EM and MacNee W Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. 2002 Eur. J. Immunol. pmid:11813158
Claing A et al. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. 2002 Br. J. Pharmacol. pmid:11815379
Chen WM et al. [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits]. 2002 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12584792